ロード中...
ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer
The uncommonness of gallbladder cancer in the developed world has contributed to the generally poor understanding of the disease. Our integrated analysis of whole exome sequencing, copy number alterations, immunohistochemical, and phospho‐proteome array profiling indicates ERBB2 alterations in 40% e...
保存先:
| 出版年: | Int J Cancer |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Inc.
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6378102/ https://ncbi.nlm.nih.gov/pubmed/30304546 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.31916 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|